Articles & Video
Decentralized and Hybrid Clinical Trials Report 2020
Our Decentralized and Hybrid Clinical Trials Report looks at how the industry is adopting virtual trials, as well as challenges that need to be overcome.
Clinical Trials Content Library: Whitepapers and Reports Collection
Explore our collection of exclusive whitepapers and reports covering the hottest topics in clinical trials with one simple registration.
Evotec to set up service to speed drug R&D in future pandemics
Evotec has set up a “pre-competitive” initiative to support customers’ drug and vaccine R&D efforts in the event of future pandemics.
Cancer drug trials getting harder due to demand and growing complexity, Tufts
Cancer trials are getting harder according to Tufts, which says increasing scale and complexity combined with the focus on subpopulations have increased the risk of undertaking such research.
Icon aims to raise $2bn through share offer to part fund PRA takeover
Icon plans to raise $2 billion to help fund the planned $12 billion acquisition of PRA Health Sciences.
Medidata launches tech to tackle patient engagement issues
Medidata aims to increase engagement and awareness for patients before and after clinical trials with the launch of myMedidata Registries.
Trial productivity flat in 2020 but efficiency efforts show promise, IQVIA
Clinical development productivity climbed only slightly in 2020 according to IQVIA’s Institute for human data science, which says longer trials and biopharma’s focus on more complex are the key dynamics.
PE interest in CRO and services sector growing, says report
COVID-19 has increased demand for clinical trials and related services, creating opportunities for private equity (PE) investors, according to new analysis.
Survey highlights lack of minority leadership in life science space
The lack of ethnic minorities and women in leadership roles is the biggest problem with diversity and inclusion in the life sciences space, according to a survey from Informa Connect.
Labcorp builds in oncology with combined trials and testing service
Labcorp has launched an “oncology platform” that combines drug development services and diagnostic testing.
Your Questions Answered: The Role of Real-world Evidence in clinical development and product registration
Dr Boxiong Tang, Head of Health Economics and Outcomes Research at BeiGene, answers questions on the role of Real-world Evidence in clinical development and product registration.
Medpace says careful project selection is key
Medpace says taking on the right clinical projects, working with a range of technologies and across a broad range of therapeutic areas is core to its strategy.
Adoption of Decentralized Clinical Trials | eBook Series
In this edition of the Clinical Trials eBook Series, we explore the rapidly increasing adoption of decentralized clinical trials and the challenges that still need to be overcome.
Back to business? Demand for trials returning, says Icon
Icon says demand is recovering with bookings for its own services as well as those of soon-to-be acquired PRA continuing to climb in the second quarter.
Trial payment firm Greenphire to be acquired by PE
Private equity (PE) firm Thoma Bravo will take over global clinical trial financial software firm Greenphire from The Riverside Company.
Life Sciences Survey: COVID-19 Impacts One Year On
Take part in our industry survey on the impacts of COVID-19 on the life sciences one year on to get exclusive early access to the final report.
Eurofins to help expand COVID-19 testing in US schools and beyond
The US Government has asked Eurofins Scientific’s contract analysis arm to further expand COVID-19 testing in schools, underserved populations, and homeless shelters.
PE firm Keensight taking major stake in Dutch CRO Symeres
Keensight Capital says the high annual growth rate in the drug discovery CRO space helped drive the acquisition of a major stake in Symeres.
Castor: Demand for decentralized trial tech growing due to pandemic
COVID-19 has increased demand for decentralized clinical trials according to Castor, which says its technology is being used to support more than 250 studies targeting the disease and the SARS-CoV-2 virus in 40 countries.
PPD setting up biomarker and bioanalysis lab in Suzhou, China
PPD says new multipurpose lab in Suzhou will help local drug developers and international firms targeting the Chinese market.